ATRA vs IT · rev $128.9M vs P/E 16, rev $6.27B
Atara Biotherapeutics Inc (ATRA) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ATRA currently screens at market cap $87.1M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ATRA and IT stock pages for the full models.
Not investment advice.